These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 8120733)

  • 21. Visible Particulate Contamination Control for Injectable Products: A Life-Cycle Approach.
    Langille SE
    PDA J Pharm Sci Technol; 2020; 74(3):359-366. PubMed ID: 31732691
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmaceutical feasibility of sub-visible particle analysis in parenterals with reduced volume light obscuration methods.
    Hawe A; Schaubhut F; Geidobler R; Wiggenhorn M; Friess W; Rast M; de Muynck C; Winter G
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1084-7. PubMed ID: 23454051
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Particulate matter content of D5/NS for injection.
    J Parenter Sci Technol; 1989; 43(2):53-5. PubMed ID: 2633761
    [No Abstract]   [Full Text] [Related]  

  • 24. USP publishes enforceable chapter on sterile compounding.
    Thompson CA
    Am J Health Syst Pharm; 2003 Sep; 60(18):1814, 1817-8, 1822. PubMed ID: 14521028
    [No Abstract]   [Full Text] [Related]  

  • 25. Parameter for assessing parenteral cleanliness based on particle-size distributions.
    Blanchard J; Schwartz JA; Byrne DM
    J Pharm Sci; 1977 Aug; 66(8):1083-6. PubMed ID: 894493
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The pharmacopeial evolution of intralipid injectable emulsion in plastic containers: from a coarse to a fine dispersion.
    Driscoll DF
    Int J Pharm; 2009 Feb; 368(1-2):193-8. PubMed ID: 18996455
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Particulate matter determination in LVPs produced in Dutch hospital pharmacies, Part 1: Particle-counting accuracy.
    Van der Veen J; Verbrugge P; Van de Vaart FJ; Boom FA
    PDA J Pharm Sci Technol; 1997; 51(2):81-8. PubMed ID: 9146039
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative estimation of particulate matter in pharmaceutical preparations intended for intravenous administration.
    Bikhazi AB; Shiatis JA; Haddad AF
    J Pharm Sci; 1977 Feb; 66(2):181-6. PubMed ID: 839413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Filtering effectiveness of conventional 15 m micron filters (DIN 58362) and newly developed 15 m micron and 5 m micron filters. I: Particle count].
    Walpot H; Franke RP; Burchard WG; Agternkamp C; Müller FG; Mittermayer C; Kalff G
    Infusionstherapie; 1989 Apr; 16(2):77-80. PubMed ID: 2737765
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microbiologic quality assurance for intravenous admixtures in a small hospital.
    Doss HL; James JD; Killough DM; Snodgrass GL
    Am J Hosp Pharm; 1982 May; 39(5):832-5. PubMed ID: 6805321
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monitoring of subvisible particles in therapeutic proteins.
    Singh SK; Toler MR
    Methods Mol Biol; 2012; 899():379-401. PubMed ID: 22735966
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A new coincidence model for single particle counters, Part II: Advances and applications.
    Knapp JZ; Lieberman A; Abramson LR
    PDA J Pharm Sci Technol; 1994; 48(5):255-92. PubMed ID: 8000900
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Particulate matter counting: the technical issues.
    Knapp JZ
    J Parenter Sci Technol; 1988; 42(1):2-8. PubMed ID: 3361403
    [No Abstract]   [Full Text] [Related]  

  • 34. Particulate matter test in small volume parenterals: critical aspects in sampling methodology.
    Pavanetto F; Conti B; Genta I; Ponci R; Montanari L; Grassi M
    Farmaco; 1989 Jun; 44(6):633-43. PubMed ID: 2803449
    [TBL] [Abstract][Full Text] [Related]  

  • 35. United States Parmacopeia Chapter <797> timeline: 1989 to 2013.
    Newton DW
    Int J Pharm Compd; 2013; 17(4):283-8. PubMed ID: 24261142
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Method for determination and element analysis of particulate contamination in injectable solutions.
    Winding O; Holma B
    Am J Hosp Pharm; 1976 Nov; 33(11):1154-9. PubMed ID: 998621
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Determination of particulate matter in small volume antibiotic injections].
    Niizeki M; Tanno K
    Jpn J Antibiot; 1989 Mar; 42(3):567-72. PubMed ID: 2746842
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Particulate matter standards for small-volume injections.
    Belson JJ
    Am J Hosp Pharm; 1986 Jun; 43(6):1527-8. PubMed ID: 3728492
    [No Abstract]   [Full Text] [Related]  

  • 39. Examination of microbiological quality of pharmaceutical raw materials.
    Bomblies L; Weiss C; Beckmann G
    Pharmeur Sci Notes; 2007 Sep; 2007(1):1-7. PubMed ID: 17993088
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Japanese pharmacopeial perspectives on particle measurement of injections.
    Fujishita O; Sendo T; Otsubo K; Aoyama T
    J Pharm Sci Technol; 1994; 48(3):148-54. PubMed ID: 8069516
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.